Search

Displaying results 8391 - 8400 of 8691 in total
  1. Drug

    Tanomastat

    go.drugbank.com/drugs/DB06276
    Experimental

  2. Drug

    Pramiconazole

    go.drugbank.com/drugs/DB06295
    Experimental

  3. Drug

    LX-2931

    go.drugbank.com/drugs/DB06297
    Investigational

  4. Drug

    Ilodecakin

    go.drugbank.com/drugs/DB06449
    Investigational

  5. Drug

    Bivatuzumab

    go.drugbank.com/drugs/DB06550
    Investigational

    Bivatuzumab (previously BIWA 4) is a humanized monoclonal antibody against CD44 v6.

  6. Drug

    Odiparcil

    go.drugbank.com/drugs/DB06609
    Investigational

  7. Drug

    Dexloxiglumide

    go.drugbank.com/drugs/DB04856
    Investigational

    Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist in phase III testing by Rottapharm in Europe only, as U.S. trials have been discontinued.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2B6 Substrates
  8. Drug

    Sivifene

    go.drugbank.com/drugs/DB05686
    Investigational

  9. Drug

    HE-2200

    go.drugbank.com/drugs/DB06257
    Experimental

  10. Drug

    Folitixorin calcium

    go.drugbank.com/drugs/DB05308
    Investigational

    ANX-510 (CoFactor) is a folate-based biomodulator drug being developed to enhance the activity and reduce associated toxicity of the widely used cancer chemotherapy, 5-fluorouracil (5-FU). CoFactor use with 5-FU is being evaluated in cli...